| Autor: |
Shahady, Edward, Leahy, John L. |
| Předmět: |
|
| Zdroj: |
Clinical Diabetes; Summer2019, Vol. 37 Issue 3, p211-220, 10p |
| Abstrakt: |
New treatments for type 2 diabetes are required to demonstrate cardiovascular safety in dedicated cardiovascular outcomes trials (CVOTs). This article reviews available evidence on cardiovascular, renal, and safety outcomes from CVOTs and real-world analyses of sodium-glucose cotransporter 2 inhibitors, along with considerations for their use in clinical practice. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
